Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M W Brechbiel

Showing results (31-40 of 114) with videos related to

Pageof 12
Sort By:
Cancer Research|July 15, 1990
Improved in vivo stability and tumor targeting of bismuth-labeled antibodyC L Ruegg, W T Anderson-Berg, M W Brechbiel, et al.
Cancer Research|October 15, 1992
Effective alpha-particle-mediated radioimmunotherapy of murine leukemiaR B Huneke, C G Pippin, R A Squire, et al.
Bioorganic & Medicinal Chemistry|January 13, 2000
Improved synthesis of the bifunctional chelating agent 1,4,7,10-tetraaza-N-(1-carboxy-3-(4-nitrophenyl)propyl)-N',N'',N'''-tri s(acetic acid)cyclododecane (PA-DOTA)L L Chappell, B E Rogers, M B Khazaeli, et al.
Nuclear Medicine and Biology|April 1, 1995
A rapid, single vessel method for preparation of clinical grade ligand conjugated monoclonal antibodiesT K Nikula, M J Curcio, M W Brechbiel, et al.
Nuclear Medicine and Biology|August 6, 2003
Synthesis and evaluation of novel bifunctional chelating agents based on 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid for radiolabeling proteinsL L Chappell, D Ma, D E Milenic, et al.
Investigative Radiology|November 18, 1998
Dysprosium-DOTA-PAMAM dendrimers as macromolecular T2 contrast agents. Preparation and relaxometryJ W Bulte, C Wu, M W Brechbiel, et al.
Magnetic Resonance Imaging|January 1, 1995
Biodistribution and metabolism of targeted and nontargeted protein-chelate-gadolinium complexes: evidence for gadolinium dissociation in vitro and in vivoF N Franano, W B Edwards, M J Welch, et al.
Bioconjugate Chemistry|July 1, 1992
An improved method for labeling monoclonal antibodies with samarium-153: use of the bifunctional chelate 2-(p-isothiocyanatobenzyl)-6- methyldiethylenetriaminepentaacetic acidM E Izard, G R Boniface, K L Hardiman, et al.
Magnetic Resonance in Medicine|March 10, 2001
3D-micro-MR angiography of mice using macromolecular MR contrast agents with polyamidoamine dendrimer core with reference to their pharmacokinetic propertiesH Kobayashi, N Sato, A Hiraga, et al.
Magnetic Resonance in Medicine|September 11, 2001
Novel intravascular macromolecular MRI contrast agent with generation-4 polyamidoamine dendrimer core: accelerated renal excretion with coinjection of lysineH Kobayashi, N Sato, S Kawamoto, et al.
Pageof 12

Showing results (31-40 of 114) with videos related to

Sort By:
Pageof 12
Cancer Research|July 15, 1990
Improved in vivo stability and tumor targeting of bismuth-labeled antibodyC L Ruegg, W T Anderson-Berg, M W Brechbiel, et al.
Cancer Research|October 15, 1992
Effective alpha-particle-mediated radioimmunotherapy of murine leukemiaR B Huneke, C G Pippin, R A Squire, et al.
Bioorganic & Medicinal Chemistry|January 13, 2000
Improved synthesis of the bifunctional chelating agent 1,4,7,10-tetraaza-N-(1-carboxy-3-(4-nitrophenyl)propyl)-N',N'',N'''-tri s(acetic acid)cyclododecane (PA-DOTA)L L Chappell, B E Rogers, M B Khazaeli, et al.
Nuclear Medicine and Biology|April 1, 1995
A rapid, single vessel method for preparation of clinical grade ligand conjugated monoclonal antibodiesT K Nikula, M J Curcio, M W Brechbiel, et al.
Nuclear Medicine and Biology|August 6, 2003
Synthesis and evaluation of novel bifunctional chelating agents based on 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid for radiolabeling proteinsL L Chappell, D Ma, D E Milenic, et al.
Investigative Radiology|November 18, 1998
Dysprosium-DOTA-PAMAM dendrimers as macromolecular T2 contrast agents. Preparation and relaxometryJ W Bulte, C Wu, M W Brechbiel, et al.
Magnetic Resonance Imaging|January 1, 1995
Biodistribution and metabolism of targeted and nontargeted protein-chelate-gadolinium complexes: evidence for gadolinium dissociation in vitro and in vivoF N Franano, W B Edwards, M J Welch, et al.
Bioconjugate Chemistry|July 1, 1992
An improved method for labeling monoclonal antibodies with samarium-153: use of the bifunctional chelate 2-(p-isothiocyanatobenzyl)-6- methyldiethylenetriaminepentaacetic acidM E Izard, G R Boniface, K L Hardiman, et al.
Magnetic Resonance in Medicine|March 10, 2001
3D-micro-MR angiography of mice using macromolecular MR contrast agents with polyamidoamine dendrimer core with reference to their pharmacokinetic propertiesH Kobayashi, N Sato, A Hiraga, et al.
Magnetic Resonance in Medicine|September 11, 2001
Novel intravascular macromolecular MRI contrast agent with generation-4 polyamidoamine dendrimer core: accelerated renal excretion with coinjection of lysineH Kobayashi, N Sato, S Kawamoto, et al.
Pageof 12